Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Suzhou Pharma Services www.suzhoupharma.com , an affiliate of Amerigen Pharmaceuticals, a new contract development and manufacturing organization specializing in solid oral dosage forms, is proud to announce the location of our new corporate ...
read more
Friday, December 07, 2012
Suzhou Pharma Services, a contract development and manufacturing organization has received the latest 2010 cGMP certification from the Chinese SFDA for their development and manufacturing facility located in the Suzhou Industrial Park, Suzhou, China....
read more
SwiftScale Biologics has successfully manufactured a COVID-19 neutralizing antibody candidate at clinical scale.
read more
Sygnature Discovery announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line expands the company’s portfolio into formal preclinical drug development. A new world-class facility with ...
read more
Wednesday, January 19, 2022
In a broad career, Dr Woler has held multiple key roles in the sector, including CEO at Roche France, Executive Chairman for Europe at SmithKline Beecham PLC, and CEO at Cadus Pharmaceutical in the US.
read more
Tuesday, December 17, 2019
Contract Manufacturing Organization (CMO) Symbiosis Pharmaceutical Services has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%.
read more
Symbiosis Pharmaceutical Services has secured £1million of finance from Allied Irish Bank (GB) to support its 2020 growth strategy.
read more
Friday, September 28, 2018
Symbiosis Pharmaceutical Services has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK.
read more
Symbiosis has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222.
read more
Wednesday, February 02, 2022
Syner-G BioPharma Group announced the acquisition of Impact Pharmaceutical Services. Based in Research Triangle Park, NC, IMPACT supports the outsourced medical writing, regulatory strategy, and regulatory publishing and submission needs of biotech ...
read more
Monday, September 28, 2020
T-knife GmbH and Catalent announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor program.
read more
Takara Bio announced the MPA has granted a manufacturing license for derivation and banking of human embryonic stem cells to be produced under GMP conditions within Takara Bio Europe's facility.
read more
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more
Monday, February 24, 2020
Taro is voluntarily recalling two lots of Phenytoin Oral Suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level.
read more
Thursday, November 05, 2020
Taysha Gene Therapies and Catalent announced a partnership to support the development and manufacturing of Taysha’s gene therapies at Catalent’s Maryland-based gene therapy facilities.
read more